Detalhe da pesquisa
1.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494698
2.
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.
Br J Haematol
; 204(5): 1825-1829, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286472
3.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067996
4.
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
Am J Hematol
; 98(1): 49-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226510
5.
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 136(21): 2401-2409, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730586
6.
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.
Hematol Oncol
; 40(4): 695-703, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488778
7.
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
Am J Hematol
; 97(5): 630-637, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156231
8.
Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study.
J Oncol Pharm Pract
; 28(2): 425-433, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719723
9.
Impact of Benzodiazepine Use on Length of Stay and 30-Day ED Visits among Hospitalized Hematopoietic Stem Cell Transplant Recipients.
South Med J
; 115(12): 936-943, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455905
10.
Utilization of radiation therapy in multiple myeloma: trends and changes in practice.
Ann Hematol
; 100(3): 735-741, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438047
11.
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia.
Am J Hematol
; 96(8): 945-953, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909933
12.
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis.
Biol Blood Marrow Transplant
; 26(1): 76-82, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31494227
13.
Antibody-based immunotherapy for treatment of immunoglobulin light-chain amyloidosis.
Br J Haematol
; 191(5): 673-681, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298469
14.
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma.
Blood
; 132(3): 293-306, 2018 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695516
15.
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.
Haematologica
; 105(2): 348-357, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004029
16.
Multiple Myeloma in the Time of COVID-19.
Acta Haematol
; 143(5): 410-416, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305989
17.
Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation Recipients.
Psychosomatics
; 61(4): 363-370, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359775
18.
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
Biol Blood Marrow Transplant
; 25(8): 1695-1700, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132453
19.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma.
Blood
; 130(10): 1198-1204, 2017 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28684537
20.
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Blood
; 140(18): 1997-2000, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096078